Adeno-Associated Virus-Based Gene Therapy for CNS Diseases

Area of Science:

• Neurology
• Molecular Biology
• Biotechnology

Background:

• Gene therapy presents a revolutionary approach for treating central nervous system (CNS) disorders.
• Adeno-associated virus (AAV)-mediated gene transfer is a key technology due to its safety and efficiency.
• AAV vectors can transduce diverse cell types, making them suitable for various CNS conditions.

Purpose of the Study:

• To review significant advancements in preclinical and clinical AAV-based CNS gene therapy.
• To explore future development prospects for AAV gene therapy in CNS disorders.

Main Methods:

• Literature review of preclinical and clinical studies on AAV-based CNS gene therapy.
• Analysis of new generation AAV vectors and delivery methods.

Main Results:

• AAV gene therapy shows significant progress in treating a wide range of CNS disorders.
• Novel AAV vectors and delivery strategies are enhancing therapeutic potential.
• Single administration of AAV vectors can provide durable therapeutic protein expression.

Conclusions:

• AAV-based gene therapy is a rapidly advancing field with substantial potential for CNS disorder treatment.
• Continued innovation in vector technology and delivery systems will drive future therapeutic success.
• AAV gene therapy holds promise for durable, single-administration treatments for CNS conditions.